LakeShore Biopharma Co. L... (LSB)
NASDAQ: LSB
· Real-Time Price · USD
0.79
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
0.79
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
LakeShore Biopharma Ltd Balance Sheet Statement
Financials in CNY. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Cash & Equivalents | 246.35M | 222.66M | 259.91M | 94.75M | 370.11M | 500.59K | 4.13M | 4.58M | 5.64M | 6.94M | 12.03M | n/a | n/a |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 1.44B | 1.34B | 1.27B | 1.27B | 1.29B | 1.29B | n/a | n/a |
Other Long-Term Assets | 57.99M | 104.96M | 28.03M | 27.07M | 20.92M | n/a | n/a | n/a | n/a | n/a | n/a | 1.59M | 596.26K |
Receivables | 444.16M | 403.12M | 429.37M | 495.91M | 463.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 205.09M | 190.78M | 212.82M | 182.37M | 185.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 7.57M | 77.23K | 11.34M | 223.21M | 10.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 903.17M | 826.77M | 934.61M | 1.01B | 1.04B | 2.06M | 4.23M | 4.98M | 6.54M | 8.37M | 14.05M | n/a | n/a |
Property-Plant & Equipment | 480.62M | 568.83M | 571.29M | 577.81M | 582.89M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 71.25M | n/a | 74.64M | 76.33M | 78.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 609.86M | 683.96M | 676.68M | 683.7M | 683.77M | 1.44B | 1.34B | 1.27B | 1.27B | 1.29B | 1.29B | 1.59M | 596.26K |
Total Assets | 1.51B | 1.51B | 1.61B | 1.69B | 1.72B | 1.44B | 1.35B | 1.28B | 1.28B | 1.3B | 1.31B | 1.59M | 596.26K |
Account Payables | 67.77M | 10.92M | 11.64M | 10.18M | 80.44M | 267.05M | n/a | 195.72M | n/a | n/a | n/a | n/a | n/a |
Deferred Revenue | n/a | 391.51M | 2.3M | 2.3M | 2.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 318.54M | 423.88M | 25.03M | 23.65M | 193.74M | 1.17B | n/a | 709.76M | n/a | n/a | n/a | 262.62K | 32.69K |
Other Current Liabilities | 163.16M | -1.1M | 1.18B | 1.11B | 108.8M | -3.43B | 2.62M | 600.47M | -170M | 711.61K | 5.06M | 1.19M | 424.15K |
Total Current Liabilities | 802.23M | 883.02M | 663.12M | 651.74M | 658.76M | 4.5M | 2.62M | 845.55K | 907.97K | 711.61K | 5.06M | 1.45M | 456.85K |
Long-Term Debt | 98.98M | 125.09M | 361.97M | 343.29M | 293.79M | 2.03B | n/a | 1.61B | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 24.83M | 5.81M | 2.19M | 2.38M | 8.79M | -2.21B | 26.86M | 8.7B | 284.47M | 107.16M | 115.36M | n/a | n/a |
Total Long-Term Liabilities | 125.6M | 131.47M | 391.07M | 377.39M | 332.54M | 40.17M | 73.76M | 81.75M | 128.65M | 152.33M | 160.62M | n/a | n/a |
Total Liabilities | 927.82M | 1.04B | 1.05B | 1.03B | 991.3M | 44.67M | 76.38M | 82.59M | 129.56M | 153.04M | 165.69M | 1.45M | 456.85K |
Total Debt | 424.46M | 558.2M | 554.2M | 526.61M | 498.63M | n/a | n/a | n/a | n/a | n/a | n/a | 262.62K | 32.69K |
Common Stock | 26.11K | 12K | 12.3K | 12K | 12.3K | 1.44B | 1.34B | 3.65K | 3.66K | 3.71K | 6.05K | 4.27K | 3.75K |
Retained Earnings | -2.31B | -2.13B | -2.05B | -1.94B | -1.87B | -42.61M | -72.16M | -77.44M | -122.98M | -144.66M | -30.29M | -23.87K | -23.73K |
Comprehensive Income | -58.18M | -56.07M | -51.25M | -52.57M | -54.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 585.21M | 474.6M | 557.1M | 660.75M | 728.45M | 1.39B | 1.27B | 1.19B | 1.15B | 1.15B | 1.14B | 140.23K | 139.41K |
Total Investments | n/a | n/a | n/a | n/a | n/a | 1.44B | 1.34B | 1.27B | 1.27B | 1.29B | 1.29B | n/a | n/a |